Investigating Ketamine for Parkinson’s Disease

by Abby McVay | Jun 23, 2021 | Clinical Trials, FDA, Genetics, Medicine, Pharmaceuticals, Product Development

medical vials and syringe

In May 2021, the FDA approved an Investigational New Drug (IND) application from PharmaTher Holdings Ltd., to proceed with a Phase Two clinical trial. PharmaTher Holdings Ltd. is a psychedelics biotech organization that focuses on research and development, and commercialization of psychedelics to treat pain and neurological disorders, and mental illnesses. This company is headquartered in Vancouver, Canada.

The Phase Two clinical trial will evaluate and establish the efficacy, safety, and pharmacokinetics of ketamine to treat patients with Parkinson’s disease. PharmaTher plans to begin the trial in the third quarter of 2021.

Parkinson’s disease is a disorder that affects over one million individuals in the United States alone, and more than seven million worldwide. Parkinson’s disease is a neurogenerative disorder that affects the central nervous system, especially the motor nerve system. Symptoms of Parkinson’s emerge slowly and include postural instability, tremors, cognitive and sensory problems, and automatic dysfunction, like hypotension. Currently, there is no cure for Parkinson’s disease. There are drug combinations that help decrease the disease’s symptoms and side effects.

Ketamine is an FDA-approved NMDA, or N-Methyl-D-Aspartate, which is a receptor-modulating drug utilized as an anesthetic agent. There was a therapeutic effect of ketamine on patients who have Parkinson’s disease. Ketamine also has additional benefits in treating symptoms of Parkinson’s disease, like pain and depression, which are frequent comorbidities of Parkinson’s disease.

If you need help with the FDA regulatory, quality, or compliance aspect of your product, EMMA International’s team of experts has you covered. Contact us at 248-987-4497, or email info@emmainternational.com today!

¹ PharmaTher Holdings Ltd. (2021, May 17). PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease. GlobeNewswire News Room; PharmaTher Holdings Ltd. ttps://www.globenewswire.com/news-release/2021/05/17/2230622/0/en/PharmaTher-Announces-FDA-Approval-of-Ketamine-IND-In-The-Treatment-of-Parkinson-s-Disease.html

Abby McVay

Abby McVay

Research Analyst- Ms. McVay is EMMA International’s Research Analyst. She has experience in technical writing and clinical trials in many life science industries. She has experience with many different elements of quality and regulatory compliance. Ms. McVay holds a Bachelor of Science in Psychology from Manchester University as well as a Master of Science in Industrial and Organizational Psychology from Angelo State University.

More Resources

Establishing a Culture of Compliance

Establishing a Culture of Compliance

While having robust compliance policies and procedures in place is essential for meeting regulatory requirements, it's equally important to establish a culture of compliance within your organization. A culture of compliance means that every employee understands the importance of compliance and is committed to upholding it in all their work. Here are some tips for establishing a culture of compliance...

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.

Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...

See All Resources

Ready to learn more about working with us?

Diverse businesspeople gathered together for negotiations lead by african businesswoman

Pin It on Pinterest

Share This